Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
When the tumor suppressor p53 is lost, it doesn't just remove a brake on cell growth — it rewires how growth signals are organized across tissue. Mount Sinai researchers found that p53 loss creates a spatial gradient of Wnt signaling that helps mutant cells steadily crowd out healthy neighbors. The key isn't how much Wnt activity is present, but how it's arranged in space.
P53 is the most commonly mutated tumor suppressor in human cancer — and when it's lost, the consequences go far beyond simply lifting a brake on cell growth. A new study published in Science by researchers at the Icahn School of Medicine at Mount Sinai reveals that p53 loss actively reshapes how growth signals are organized across tissue, giving mutant cells a strategic edge over their normal neighbors.
Using mouse skin as a model, the team tracked how p53-deficient cell clusters expand through normal tissue. They found the expansion was driven not by faster cell division or less cell death, but by a shift in cell fate — mutant cells were more likely to keep renewing themselves rather than maturing into specialized cells. Three p53-regulated genes (Sfrp1, Lrp1, and Usp22) normally keep Wnt signaling in check; without p53, Wnt activity rises and organizes into a persistent spatial gradient that fuels expansion.
Key Takeaways:
Why it matters: Most of us accumulate cancer-associated mutations in our tissues as we age, yet most never become tumors. This research offers a new framework for understanding how p53 loss can quietly tip that balance — long before a tumor ever forms — and highlights spatial signaling organization as a potential new target for early cancer intervention.
